The company said, “It is with great sorrow that National Health Investors (NHI) acknowledges the loss of our long-time colleague and great friend, Joe Wakham. Joe was with NHI for 16 years and his personality and influence is woven into the cultural fabric of our Company. Joe started with NHI as an accountant in 2009. Joe distinguished himself as our Director of Financial Reporting and is considered the “father” of the NHI supplemental report as it is crafted today. Joe also volunteered for many of the early information technology projects we had due to his love and understanding of technology. Joe was promoted to Assistant Controller in November 2019 and became our Controller and Vice President in June 2020.”
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NHI:
- National Health Investors Revamps Board for Transparency
- National Health Investors appoints Robert McCabe as chair
- National Health Investors price target lowered to $66 from $77 at Jefferies
- National Health Investors price target lowered to $72 from $78 at Truist
- National Health Investors price target lowered to $76 from $80 at Wells Fargo